Emerging markets | China Time to turn positive on China equities?

Bin Shi, our Head of China equities, explained at webinar that he sees a turning point in both the Chinese government policy and the outlook for China’s equity markets.

08 Nov 2018

We expect that economic fundamentals will bottom early next year and that the impacts of both recent and forthcoming policy changes will be felt soon after, with a likely improvement in sentiment and an upturn in the Chinese equity market.

We have also collated his views in the Q&A below.

You have recently changed your views on the China equity market, why?

We took a very cautious view on the market in the first three quarters of 2018, mainly because of the government's tough deleveraging and regulatory policies, as well as the US/China trade dispute.

But looking at a series of recent policy statements and news announcements, we believe there has been a significant change in the Chinese government's attitude which means both targeted support for the economy and the possibility of a compromise on US/China trade issues.

Can you explain your point on the likelihood of a compromise on US/China trade issues?

Restrictions on overseas investors' ability to invest in key industries, like autos and finance, have been a major sticking point in the US/China trade dispute.

However, we have seen a number of recent cases where the Chinese government has approved a series of major investments in China by overseas auto and financial services companies. These cases tell us that the Chinese government is moving to address the root cause of the trade disputes.

Given the clear signs that the Chinese government is working to allay concerns on the US side, there's a stronger likelihood of a compromise.

And looking at recent agreements with Canada and Mexico, it's clear the US is amenable to trade dispute solutions.

Furthermore, trade wars are harmful for both sides, and recent adjustments in US equities tell us that concerns are growing in the US about the effects of the trade war, which we think will ultimately put pressure on the government to act.

For further visibility on the path of the trade dispute, the tone coming from the meeting between Presidents Trump and Xi Jinping at the coming G20 gathering in November will be key, particularly because the US mid-term elections will have passed by then.

Can you give any more details about how the Chinese government's policy attitude has changed?

President Xi Jinping, Premier Li Keqiang, as well as senior leaders in the Ministry of Finance, People's Bank of China, and China Banking and Regulatory Commission have all recently stated that the government will offer targeted policy assistance for private enterprises in the coming months and will take steps to support capital markets and business confidence.

This amounts to a 180-degree change in the government's policy direction. As this is a unified policy stance across all major government departments, we think it is highly significant because it means there will be a series of follow-through policies to come.

And we are already seeing evidence of policy support already being applied in China. For example, the government has cut social security taxes previously imposed on the private sector, as well as reducing value-added and private equity taxes.

You said that policy has changed but when do you expect we will see the effects?

Investor sentiment is the key issue here and we believe it will take time to rebuild confidence in the market.

Importantly, policy turning points are usually ahead of changes in the market because it takes time for policy changes to have a noticeable effect on the economy.

We expect that economic fundamentals will bottom early next year and that the impacts of both recent and forthcoming policy changes will be felt soon after, with a likely improvement in sentiment and an upturn in the Chinese equity market.

Policy has changed but what about market valuations, how do you see the market now?

Current valuation levels are low compared to both historical trends and to markets across Asia.

10 Years' History: 12M Forward P/E Ratio

Looking back a little, how does the sell-off seen in 2018 differ from that seen in 2015?

The situation in 2015 was completely different. Margin financing grew markedly in the years leading up to the 2015 sell-off. In 2015, the government cracked down on margin financing and dramatically reduced market liquidity, thus causing a prolonged sell-off.

What we have seen in 2018 has been different. Structural issues, like the build-up of debt and the government's strict approach to tackling it through deleveraging policies, have hit the markets, and the trade dispute with the US compounded the situation.

Now you are more positive about the market, what's your view on prospects for A- and H-shares?

In the short-term, the outlook for A-shares may be more positive since the specific policies announced by the government are intended to support that particular market.

Looking longer term, the macro background of the A- and H-share markets are basically the same, so it's likely that valuations will converge over time.

That said, we believe that the differentiation between the two markets will become less important over time. We are focused in looking for opportunities in either market that are best set to benefit from China's growth over the long term. 

12month forward P/E

Looking now at particular sectors, what's your view on financials?

Prospects for the financial sector have improved now that the government has turned more supportive to the economy, which we feel has reduced risks to the financial system.

Currently, valuations for the banking and insurance sector are low and we have added selectively by investing in names that we think have the best prospects.

We have to be selective and focused on financial companies we feel have the ability to be competitive in the long-run because the financial sector still faces risks from non-performing loans and the growth of internet finance.

Have you changed your position on China's education sector?

Government regulations have impacted the whole of China's after-school education industry and that's affected expectations about future growth and valuations. That said, we remain positive on both the sector and leading names within it. Specifically, we think the larger names in the sector have both the resources and the operational ability to adjust to the new policy environment, while it may be difficult for smaller names to adjust.

As such, we expect smaller players will be forced out as the new regulations kick in. This means that the larger companies in the sector will ultimately be able to increase their market share, which is positive for their future. After all, fundamental industry drivers, like urbanization and rising incomes, are still growing strongly.

How will you change your investment strategy given the change in policy direction?

We will likely be more offensive in our equity allocations and put cash to work in the near future.

During the first half of 2018, our cash levels were around 20% because of weaker sentiment and heightened volatility in the market but our levels are now at 16%.

We will, however, remain disciplined in our investment approach and maintain our focus on companies that we believe will deliver growth over the long-term. We continue to be positive on 'new economy' companies in sectors like consumer, IT, and healthcare. We'll most likely add to sectors highly impacted by government regulations, like online gaming and education, because we expect some of these regulations to be reversed in the future.

In summary, we think that investors should have reason to be more optimistic on Chinese equities and, since we see an improving outlook for the market, we believe investors should take action now.

More insights

Singapore Retail Investors


This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2020 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.